ZA952587B - Human tumor necrosis factor receptor - Google Patents

Human tumor necrosis factor receptor

Info

Publication number
ZA952587B
ZA952587B ZA952587A ZA952587A ZA952587B ZA 952587 B ZA952587 B ZA 952587B ZA 952587 A ZA952587 A ZA 952587A ZA 952587 A ZA952587 A ZA 952587A ZA 952587 B ZA952587 B ZA 952587B
Authority
ZA
South Africa
Prior art keywords
necrosis factor
tumor necrosis
factor receptor
human tumor
human
Prior art date
Application number
ZA952587A
Inventor
John M Greene
Robert D Fleischmann
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PCT/US1995/003216 priority Critical patent/WO1996028546A1/en
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to ZA952587A priority patent/ZA952587B/en
Priority to US08/469,637 priority patent/US7094564B1/en
Publication of ZA952587B publication Critical patent/ZA952587B/en
Priority to CA002211003A priority patent/CA2211003A1/en
Priority to JP2002066838A priority patent/JP2002320479A/en
Priority to US10/164,592 priority patent/US20020150989A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA952587A 1995-03-15 1995-03-29 Human tumor necrosis factor receptor ZA952587B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/US1995/003216 WO1996028546A1 (en) 1995-03-15 1995-03-15 Human tumor necrosis factor receptor
ZA952587A ZA952587B (en) 1995-03-15 1995-03-29 Human tumor necrosis factor receptor
US08/469,637 US7094564B1 (en) 1995-03-15 1995-06-06 Human tumor necrosis factor receptor
CA002211003A CA2211003A1 (en) 1995-03-15 1997-09-19 Human tumor necrosis factor receptor
JP2002066838A JP2002320479A (en) 1995-03-15 2002-03-12 Human tumor necrosis factor receptor
US10/164,592 US20020150989A1 (en) 1995-03-15 2002-06-10 Human tumor necrosis factor receptor

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1995/003216 WO1996028546A1 (en) 1995-03-15 1995-03-15 Human tumor necrosis factor receptor
ZA952587A ZA952587B (en) 1995-03-15 1995-03-29 Human tumor necrosis factor receptor
CA002211003A CA2211003A1 (en) 1995-03-15 1997-09-19 Human tumor necrosis factor receptor
JP2002066838A JP2002320479A (en) 1995-03-15 2002-03-12 Human tumor necrosis factor receptor

Publications (1)

Publication Number Publication Date
ZA952587B true ZA952587B (en) 1996-11-27

Family

ID=31721537

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952587A ZA952587B (en) 1995-03-15 1995-03-29 Human tumor necrosis factor receptor

Country Status (4)

Country Link
JP (1) JP2002320479A (en)
CA (1) CA2211003A1 (en)
WO (1) WO1996028546A1 (en)
ZA (1) ZA952587B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
US8110659B1 (en) 1995-03-15 2012-02-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like genes
US7078493B1 (en) 1995-03-15 2006-07-18 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like genes
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US7632922B1 (en) 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
WO1998012344A1 (en) * 1996-09-18 1998-03-26 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like genes
CA2266327A1 (en) * 1996-10-04 1998-04-09 Immunex Corporation Novel receptor that causes cell death
AU713473B2 (en) 1996-12-23 1999-12-02 Immunex Corporation Receptor activator of NF-kappa B, receptor is member of TNF receptor superfamily
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
KR100496063B1 (en) 1997-04-15 2005-06-21 산쿄 가부시키가이샤 Novel protein and process for producing the same
CZ302262B6 (en) 1997-04-16 2011-01-19 Amgen Inc. Isolated nucleic acid, polypeptide encoded by the nucleic acid, expression vector comprising the nucleic acid, host cell transformed or transfected with the expression vector, isolated osteoprotegerin binding protein, antibody, which specifically bin
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
WO1999015691A1 (en) 1997-09-24 1999-04-01 Snow Brand Milk Products Co., Ltd. Method for diagnosing bone dysbolism
US6297022B1 (en) 1997-10-08 2001-10-02 Smithkline Beecham Corporation Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
TR201809678T4 (en) 2001-06-26 2018-07-23 Amgen Fremont Inc Antibodies against opgl.
US7718776B2 (en) 2002-04-05 2010-05-18 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
JP4050593B2 (en) 2002-11-01 2008-02-20 日本特殊陶業株式会社 Gas sensor element and gas sensor using the same

Also Published As

Publication number Publication date
WO1996028546A1 (en) 1996-09-19
JP2002320479A (en) 2002-11-05
CA2211003A1 (en) 1999-03-19

Similar Documents

Publication Publication Date Title
EP0822984A4 (en) Human tumor necrosis factor receptors
EP0988371A4 (en) Human tumor necrosis factor receptor tr9
ZA952587B (en) Human tumor necrosis factor receptor
AU9013998A (en) Tumor necrosis factor receptor ztnfr-5
EP1007562A4 (en) TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
IL115470A (en) Therapeutic food composition
PL328822A1 (en) Human bikinine
AU7705198A (en) Human tumor necrosis factor receptor tr10
AU7705098A (en) Human tumor necrosis factor receptor-like protein 8
EP0961782A4 (en) Human tumor necrosis factor receptor-like 2
GB9509572D0 (en) Cancer therapy
HUP9802589A3 (en) Bone stimulating factor
EP0961832A4 (en) Human tumor necrosis factor receptor-like genes
AU1541699A (en) Human tumor necrosis factor-r2-like proteins
EP1009431A4 (en) Human tumor necrosis factor receptor-like 2 (tr2) antibodies
AU9130598A (en) Tumor necrosis factor receptor ztnfr-6
AU6035398A (en) Human c5a-like receptor
AU5471098A (en) Bone stimulating factor
HUP9901438A3 (en) Therapeutic pyrimidine compounds
EP0574257A3 (en) Amino-hydroxy-methyl-isoxazole-propionate binding human glutamate receptors.
EP0792282A4 (en) Human endothelin-bombesin receptor
AU3628800A (en) Human tumor necrosis factor receptor tr9
ZA968062B (en) Bone stimulating factor
AU2159995A (en) Human tumor necrosis factor receptor
GB9508640D0 (en) Sunbeds